Eupraxia Pharmaceuticals Pink Sheet Forecast - Polynomial Regression
| EPRXFDelisted Stock | USD 2.79 0.04 1.45% |
The Polynomial Regression forecasted value of Eupraxia Pharmaceuticals on the next trading day is expected to be 2.72 with a mean absolute deviation of 0.12 and the sum of the absolute errors of 7.56. Eupraxia Pink Sheet Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Eupraxia Pharmaceuticals' historical fundamentals, such as revenue growth or operating cash flow patterns.
Eupraxia |
Eupraxia Pharmaceuticals Polynomial Regression Price Forecast For the 30th of November
Given 90 days horizon, the Polynomial Regression forecasted value of Eupraxia Pharmaceuticals on the next trading day is expected to be 2.72 with a mean absolute deviation of 0.12, mean absolute percentage error of 0.04, and the sum of the absolute errors of 7.56.Please note that although there have been many attempts to predict Eupraxia Pink Sheet prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Eupraxia Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Eupraxia Pharmaceuticals Pink Sheet Forecast Pattern
| Backtest Eupraxia Pharmaceuticals | Eupraxia Pharmaceuticals Price Prediction | Buy or Sell Advice |
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Polynomial Regression forecasting method's relative quality and the estimations of the prediction error of Eupraxia Pharmaceuticals pink sheet data series using in forecasting. Note that when a statistical model is used to represent Eupraxia Pharmaceuticals pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 114.8836 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.124 |
| MAPE | Mean absolute percentage error | 0.0405 |
| SAE | Sum of the absolute errors | 7.5638 |
Predictive Modules for Eupraxia Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Eupraxia Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Eupraxia Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
View Eupraxia Pharmaceuticals Related Equities
| Risk & Return | Correlation |
Eupraxia Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Eupraxia Pharmaceuticals pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Eupraxia Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Eupraxia Pharmaceuticals pink sheet market strength indicators, traders can identify Eupraxia Pharmaceuticals entry and exit signals to maximize returns.
Eupraxia Pharmaceuticals Risk Indicators
The analysis of Eupraxia Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Eupraxia Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting eupraxia pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.65 | |||
| Standard Deviation | 5.48 | |||
| Variance | 29.99 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Currently Active Assets on Macroaxis
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Consideration for investing in Eupraxia Pink Sheet
If you are still planning to invest in Eupraxia Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Eupraxia Pharmaceuticals' history and understand the potential risks before investing.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |